Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |